Regulus Therapeutics Inc. Contracts & Agreements
110 Contracts & Agreements
- Business Finance (39 contracts)
- Business Operations (5)
- Human Resources (24)
- Intellectual Property (1)
- Real Estate (12)
- Uncategorized (29)
- Securities Purchase Agreement, dated March 11, 2024, by and among the Company and the Purchasers (Filed With SEC on March 14, 2024)
- Offer Letter Agreement, dated June 12, 2023, by and between the Registrant and Preston Klassen, M.D (Filed With SEC on August 8, 2023)
- Amendment to Loan and Security Agreement, dated June 19, 2023, by and between the Registrant and Oxford Finance, LLC (Filed With SEC on August 8, 2023)
- Description of Common Stock (Filed With SEC on March 23, 2023)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)
- Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)
- Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on August 11, 2022)
- Regulus Therapeutics Inc. 2022 Employee Stock Purchase Plan (Filed With SEC on August 11, 2022)
- Description of Common Stock (Filed With SEC on March 11, 2022)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
- Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
- Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
- Denis Drygin, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
- Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and among the Registrant and Oxford Finance, LLC (Filed With SEC on March 11, 2022)
- Eleventh Amendment to Loan and Security Agreement, dated December 31, 2021, by and between the Company and Oxford Finance LLC (Filed With SEC on January 5, 2022)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2019 (Filed With SEC on March 9, 2021)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2020 (Filed With SEC on March 9, 2021)
- Employment Agreement between the Registrant and Denis Drygin (Filed With SEC on March 9, 2021)
- Second Amendment to Loan and Security Agreement, dated March 6, 2018, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 9, 2021)
- Lease Agreement, dated February 11, 2021, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on March 9, 2021)
- Assignment and Assumption of Lease, dated February 11, 2021, by and between the Registrant and Turning Point Therapeutics, Inc (Filed With SEC on March 9, 2021)
- Form of Common Stock Purchase Warrant (Filed With SEC on December 4, 2020)
- Securities Purchase Agreement, dated December 1, 2020, by and among the Company and the Purchasers (Filed With SEC on December 4, 2020)
- Second Amendment to Second Amended and Restated Collaboration and License Agreement, dated August 25, 2020, by and between the Registrant and Sanofi (Filed With SEC on November 5, 2020)
- Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and between the Registrant and Oxford Finance, LLC (Filed With SEC on November 5, 2020)
- Ninth Amendment to Loan and Security Agreement, dated May 1, 2020, by and between the Registrant and Oxford Finance, LLC (Filed With SEC on May 14, 2020)
- Description of Common Stock (Filed With SEC on March 12, 2020)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on November 12, 2019)
- Employment Agreement, dated August 30, 2019, by and between the Registrant and Cris Calsada (Filed With SEC on November 12, 2019)
- Lease Agreement, dated June 19, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on August 8, 2019)
- First Amendment to Lease, dated June 19, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on August 8, 2019)
- Regulus Therapeutics Inc. 2019 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to the Registrants Current Report on Form 8-K (File No. 001-35670, filed with the... (Filed With SEC on August 8, 2019)
- Consulting agreement, dated July 26, 2019, by and between the Registrant and Daniel R. Chevallard (Filed With SEC on August 8, 2019)
- Offer Letter Agreement, dated July 29, 2019, by and between the Company and Cris Calsada (Filed With SEC on July 30, 2019)
- Employment Agreement between the Registrant and Christopher Aker, dated July 24, 2018 (Filed With SEC on May 10, 2019)
- Seventh Amendment to Loan and Security Agreement, dated April 9, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on May 10, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on May 9, 2019)
- Securities Purchase Agreement, dated May 3, 2019, by and among the Company and the Purchasers (Filed With SEC on May 9, 2019)
- Eighth Amendment to Loan and Security Agreement, dated May 3, 2019, by and between the Company and Oxford Finance LLC (Filed With SEC on May 9, 2019)
- Fourth Amendment to Loan and Security Agreement, dated November 5, 2018, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 18, 2019)
- First Amendment to Second Amended and Restated Collaboration and License Agreement, dated November 5, 2018, by and between the Registrant and Sanofi (Filed With SEC on March 18, 2019)
- Lease Agreement, dated February 25, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on March 18, 2019)
- Agreement, dated February 19, 2019, by and between the Registrant and Nitto Biopharma, Inc (Filed With SEC on March 18, 2019)
- Second Amendment to Lease Agreement, dated February 25, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on March 18, 2019)
- Sixth Amendment to Loan and Security Agreement, dated March 7, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 18, 2019)
- Fifth Amendment to Loan and Security Agreement, dated January 31, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on February 1, 2019)
- Common Stock Sales Agreement, dated December 12, 2018, by and between Regulus Therapeutics Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 12, 2018)
- Form of common stock certificate of the Registrant (Filed With SEC on November 9, 2018)
- Letter Agreement, dated May 8, 2018, by and between the Registrant and AstraZeneca AB (Filed With SEC on August 9, 2018)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2018 (Filed With SEC on May 10, 2018)
- Timothy Wright, Ph.D., Yearly Discretionary Base Salary Increase, effective January 1, 2018 (Filed With SEC on May 10, 2018)
- Mark Deeg, M.D., Ph.D., Yearly Discretionary Base Salary Increase, effective January 1, 2018 (Filed With SEC on May 10, 2018)
- Daniel R. Chevallard, Yearly Discretionary Base Salary Increase, effective January 1, 2018 (Filed With SEC on May 10, 2018)
- First Amendment to Loan and Security Agreement, dated October 4, 2017, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 8, 2018)
- Second Amendment to Loan and Security Agreement, dated March 6, 2018, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 8, 2018)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 2, 2017)
- Joseph P. Hagan Compensation Changes (Filed With SEC on August 2, 2017)
- RELEASE AND WAIVER OF CLAIMS (Filed With SEC on August 2, 2017)
- 44,000,000Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on July 20, 2017)
- Regulus Therapeutics Inc. Joseph P. Hagan Yearly Discretionary Base Salary Increase (Filed With SEC on May 5, 2017)
- Regulus Therapeutics Inc. Timothy Wright, Ph.D. Yearly Discretionary Base Salary Increase (Filed With SEC on May 5, 2017)
- Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase (Filed With SEC on May 5, 2017)
- NON-EMPLOYEE DIRECTOR COMPENSATION POLICY, AS ADOPTED 12/5/2016 (Filed With SEC on March 3, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 3, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on August 3, 2016)
- Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase (Filed With SEC on May 3, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 23, 2016)
- LICENSING AGREEMENT between ETH Zurich Raemistrasse 101, 8092 Zurich, Switzerland (hereinafter referred to as Licensor or ETH) and Regulus Therapeutics Inc. Rutherford Road,... (Filed With SEC on February 23, 2016)
- Paul Grint, M.D. Base Salary and Annual Bonus Increase (Filed With SEC on August 5, 2015)
- TORREY RIDGE SCIENCE CENTER LEASE WALTONTORREY OWNER B, L.L.C., a Delaware limited liability company as Landlord, and REGULUS THERAPEUTICSINC., a Delaware corporation as Tenant (Filed With SEC on August 5, 2015)
- EXHIBIT A [***] (Filed With SEC on May 8, 2015)
- Regulus Therapeutics Inc. Kleanthis G. Xanthopoulos, Ph.D. Yearly Discretionary Base Salary Increase (Filed With SEC on February 19, 2015)
- Regulus Therapeutics Inc. Neil W. Gibson, Ph.D. Yearly Discretionary Base Salary Increase (Filed With SEC on February 19, 2015)
- Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase (Filed With SEC on February 19, 2015)
- Regulus Therapeutics Inc. David L. Szekeres Yearly Discretionary Base Salary Increase (Filed With SEC on February 19, 2015)
- 5,294,118 Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 29, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2014)
- NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on February 28, 2014)
- Regulus Therapeutics Inc. Yearly Discretionary Merit Bonus Percentage of Neil W. Gibson, Ph.D. (Filed With SEC on February 28, 2014)
- SECOND AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT between REGULUSTHERAPEUTICS INC. And SANOFI SECOND AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on February 28, 2014)
- [ ] Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on June 26, 2013)
- AMENDMENT #5 TO THE PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on June 26, 2013)
- AMENDMENT Nr.1 (toCollaboration and License Agreement) (Filed With SEC on June 26, 2013)
- AMENDMENT NO. 1 TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on June 26, 2013)
- FOURTH AMENDMENT TO LEASE (Filed With SEC on February 19, 2013)
- REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 11, 2012)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 11, 2012)
- PRODUCTDEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN GLAXO GROUP LIMITED AND REGULUS THERAPEUTICS LLC (Filed With SEC on September 18, 2012)
- REGULUS THERAPEUTICS INC. 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 7, 2012 APPROVED BY THESTOCKHOLDERS: SEPTEMBER 7, 2012 IPODATE/EFFECTIVE DATE: ,... (Filed With SEC on September 7, 2012)
- NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on September 7, 2012)
- REGULUS THERAPEUTICS INC. 2012 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 7, 2012 APPROVED BY THESTOCKHOLDERS: SEPTEMBER 7, 2012 (Filed With SEC on September 7, 2012)
- [ ] Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on August 17, 2012)
- INDEMNITY AGREEMENT (Filed With SEC on August 17, 2012)
- REGULUS THERAPEUTICS INC. 2009 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 2, 2009 APPROVED BY THESTOCKHOLDERS: JANUARY 2, 2009 AMENDED BYTHE BOARD OF... (Filed With SEC on August 17, 2012)
- REGULUS THERAPEUTICS INC. 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 8, 2012 APPROVED BY THESTOCKHOLDERS: , 2012 IPODATE/EFFECTIVE DATE: , 2012 (Filed With SEC on August 17, 2012)
- NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on August 17, 2012)
- REGULUS THERAPEUTICS INC. 2012 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 8, 2012 APPROVED BY THESTOCKHOLDERS: , 2012 (Filed With SEC on August 17, 2012)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 17, 2012)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 17, 2012)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 17, 2012)
- LEASE by and between BMR-John Hopkins Court LLC, a Delaware limited liability company and Regulus Therapeutics Inc., a Delaware corporation LEASE (Filed With SEC on August 17, 2012)
- FIRST AMENDMENT TO LEASE (Filed With SEC on August 17, 2012)
- SECOND AMENDMENT TO LEASE (Filed With SEC on August 17, 2012)
- THIRD AMENDMENT TO LEASE (Filed With SEC on August 17, 2012)
- REGULUS THERAPEUTICS INC. FOUNDING INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. FOUNDING INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 17, 2012)
- AMENDMENT NUMBER ONE TO THE FOUNDING INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 17, 2012)
- AMENDMENT NUMBER TWO TO THE FOUNDING INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 17, 2012)
- REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 17, 2012)